<div>An international team of researchers has found that glycosylation patterns are conserved across the native spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) &ndash; the agent that causes coronavirus disease 2019 (COVID-19) &ndash; and the recombinant spike proteins made in laboratories for use in vaccines.</div>